Suprapubic or urethral catheter: what is the optimal method of bladder drainage after radical hysterectomy?
BACKGROUND
Lower urinary tract dysfunction is a common morbidity related to radical hysterectomy (RAH). Although transurethral catheterization (TUC) has traditionally been used for postoperative bladder drainage following RAH, suprapubic catheterization (SPC) is an alternative method that may be advantageous.


OBJECTIVE
To determine, by means of a retrospective cohort study, the incidence of urinary tract infection (UTI), duration of postoperative hospital stay, and time to trial of voiding in women catheterized suprapubically or transurethrally after RAH for early stage cervical cancer.


METHODS
Two hundred twelve patients who underwent RAH and staging for stage IA1 + LVS, 1A2, and 1B1 cancer of the cervix in Edmonton between 1996 and 2006 were included in the study. Three gynaecologic oncologists performed the surgeries. Operative, postoperative, and demographic data were extracted from patient records. Patients were catheterized either suprapubically (SPC group) or transurethrally (TUC group) according to the surgeon's discretion. Comparative tests and multivariate regression analysis were used to compare outcome measures between the groups and to adjust for confounding variables.


RESULTS
The TUC group had a higher proportion of patients with UTI (27%) than the SPC group (6%) (P < 0.001). The SPC group had a shorter postoperative hospital stay (4.8 vs. 5.7 days; P < 0.001) and an earlier trial of voiding (2.7 vs. 4.4 days; P < 0. 001). Following regression analysis, statistically significant differences remained for UTI and time to initiation of a trial of voiding.


CONCLUSIONS
After RAH for early stage cervical cancer, suprapubic catheterization is associated with a lower rate of UTI and an earlier trial of voiding than transurethral catheterization.
Wells
Tiffany H
TH
University of Alberta, Department of Obstetrics and Gynecology, Edmonton AB.
Steed
Helen
H
University of Alberta, Department of Obstetrics and Gynecology, Edmonton AB; Department of Gynecologic Oncology, Cross Cancer Institute, Edmonton AB.
Capstick
Valerie
V
University of Alberta, Department of Obstetrics and Gynecology, Edmonton AB; Department of Gynecologic Oncology, Cross Cancer Institute, Edmonton AB.
Schepanksy
Alexandra
A
University of Alberta, Department of Obstetrics and Gynecology, Edmonton AB; Department of Gynecologic Oncology, Cross Cancer Institute, Edmonton AB.
Hiltz
Michelle
M
University of Alberta, Department of Obstetrics and Gynecology, Edmonton AB.
Faught
Wylam
W
University of Alberta, Department of Obstetrics and Gynecology, Edmonton AB; Department of Gynecologic Oncology, Cross Cancer Institute, Edmonton AB.
D000328:Adult; D000368:Aged; D015331:Cohort Studies; D004322:Drainage; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007902:Length of Stay; D008875:Middle Aged; D011182:Postoperative Care; D012189:Retrospective Studies; D001743:Urinary Bladder; D014546:Urinary Catheterization / Q000009:adverse effects / Q000379:methods*; D014552:Urinary Tract Infections / Q000453:epidemiology; D014554:Urination; D055815:Young Adult